Literature DB >> 23233309

Association of an activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype with increased susceptibility to rheumatoid arthritis.

Tae-Un Han1, Soo-Kyung Cho, Taehyeung Kim, Young Bin Joo, Sang-Cheol Bae, Changwon Kang.   

Abstract

OBJECTIVE: To investigate whether a human X chromosome locus of IRAK1 and MECP2 is associated with susceptibility to rheumatoid arthritis (RA), an autoimmune disease that predominantly affects women.
METHODS: A total of 2,334 unrelated Korean participants (including 1,318 patients with RA) were genotyped for 5 tag single-nucleotide polymorphisms (SNPs) and 3 additional SNPs in an Xq28 region harboring MECP2 and IRAK1. Twenty-nine additional neighboring SNPs were imputed using the Korean HapMap Project data. All 37 SNPs were statistically tested for association with RA susceptibility, and 2 SNPs associated with RA were examined for their functional effects.
RESULTS: RA susceptibility was associated with multiple SNPs in a 79-kb linkage disequilibrium block harboring both MECP2 and IRAK1. The most significant association was for MECP2 SNP rs1734792 (P = 0.00089), but 2 nonsynonymous IRAK1 SNPs, rs1059702 (P = 0.0034) and rs1059703 (P = 0.0042), which were in strong linkage disequilibrium with the MECP2 SNP (D' = 0.87 and 0.91, respectively) affected IRAK1 protein activity. The major haplotype of the 2 nonsynonymous SNPs was associated with a 1.7-fold increase in RA susceptibility versus the minor haplotype (P = 0.0082), and with increased IRAK1 activity, which was demonstrated by a 1.7-fold increase in the intracellular activity of transcription factor NF-κB.
CONCLUSION: Our findings indicate that RA susceptibility is associated with multiple SNPs in MECP2 and IRAK1, but high linkage disequilibrium between them does not allow for further localization. Therefore, both genes remain candidates. Nevertheless, the major haplotype of the 2 nonsynonymous IRAK1 SNPs encoding for pPhe196Ser and pSer532Leu confers enhanced IRAK1 activity and, consequently, enhanced susceptibility to RA, as compared to the minor haplotype.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23233309     DOI: 10.1002/art.37804

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis : A case control study and meta-analysis.

Authors:  X-K Yang; P Li; C Zhang; R-X Leng; S Li; J Liu; B-Z Li; H-F Pan; D-Q Ye
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

2.  Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.

Authors:  Jedediah Seltzer; Razia Moorad; Jason M Schifano; Justin T Landis; Dirk P Dittmer
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

3.  Single nucleotide polymorphism of Methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis.

Authors:  Mahdi Mahmoudi; Elham Hamzeh; Saeed Aslani; Vahid Ziaee; Shiva Poursani; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2017-12-29       Impact factor: 2.980

Review 4.  Update on the genetic architecture of rheumatoid arthritis.

Authors:  Kwangwoo Kim; So-Young Bang; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Nat Rev Rheumatol       Date:  2016-11-04       Impact factor: 20.543

Review 5.  Type I interferon in rheumatic diseases.

Authors:  Theresa L Wampler Muskardin; Timothy B Niewold
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

6.  IRAK2 is associated with susceptibility to rheumatoid arthritis.

Authors:  Hana Ben Hassine; Rim Sghiri; Elyes Chabchoub; Asma Boumiza; Foued Slama; Khadija Baccouche; Zahid Shakoor; Adel Almogren; Christina Mariaselvam; Ryad Tamouza; Elyes Bouajina; Ramzi Zemni
Journal:  Clin Rheumatol       Date:  2017-11-11       Impact factor: 3.650

7.  Immune dysfunction in Rett syndrome patients revealed by high levels of serum anti-N(Glc) IgM antibody fraction.

Authors:  Anna Maria Papini; Francesca Nuti; Feliciana Real-Fernandez; Giada Rossi; Caterina Tiberi; Giuseppina Sabatino; Shashank Pandey; Silvia Leoncini; Cinzia Signorini; Alessandra Pecorelli; Roberto Guerranti; Solange Lavielle; Lucia Ciccoli; Paolo Rovero; Claudio De Felice; Joussef Hayek
Journal:  J Immunol Res       Date:  2014-10-15       Impact factor: 4.818

8.  TMEM187-IRAK1 Polymorphisms Associated with Rheumatoid Arthritis Susceptibility in Tunisian and French Female Populations: Influence of Geographic Origin.

Authors:  Olfa Khalifa; Nathalie Balandraud; Nathalie Lambert; Isabelle Auger; Jean Roudier; Audrey Sénéchal; David Geneviève; Christophe Picard; Gérard Lefranc; Isabelle Touitou; Bakridine M'Madi Mrenda; Cécilia Benedito; Etienne Pardoux; Anne-Laure Gagez; Yves-Marie Pers; Christian Jorgensen; Touhami Mahjoub; Florence Apparailly
Journal:  J Immunol Res       Date:  2017-02-08       Impact factor: 4.818

Review 9.  Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy.

Authors:  Jack W Singer; Angela Fleischman; Suliman Al-Fayoumi; John O Mascarenhas; Qiang Yu; Anupriya Agarwal
Journal:  Oncotarget       Date:  2018-09-07

10.  Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.

Authors:  Taehyeung Kim; Sang-Cheol Bae; Changwon Kang
Journal:  Arthritis Res Ther       Date:  2020-04-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.